查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1966669

基因组学实验室自动化市场分析及预测（至2035年）：按类型、产品类型、服务、技术、组件、应用、最终用户、流程、设备和解决方案划分

Lab Automation in Genomics Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, End User, Process, Device, Solutions
出版日期: | 出版商: Global Insight Services | 英文 353 Pages | 商品交期: 3-5个工作天内

价格
简介目录

基因组学实验室自动化市场预计将从2024年的24.4亿美元成长到2034年的109亿美元，复合年增长率约为16.1%。该市场涵盖了透过自动化系统简化基因组研究的技术，提高了DNA定序、PCR和样本製备的准确性和通量。这些创新减少了人为错误和营运成本，同时加快了发现的速度。在机器人和人工智慧技术进步的推动下，该市场在个人化医疗和生物技术领域至关重要，满足了基因组研究对效率和扩充性日益增长的需求。

受高通量定序和精准医疗需求不断增长的推动，基因组学实验室自动化市场正经历强劲成长。其中，自动化系统细分市场成长最快，这主要得益于先进机器人技术和人工智慧平台的整合应用。这些系统显着提升了基因组学工作流程的效率和准确性。耗材细分市场（包括试剂和检测试剂盒）成长率位居第二，这主要得益于基因组学实验中对可靠、高品质材料的持续需求。

市场区隔
类型 自动化液体处理系统、自动化微孔板处理系统、机器人系统、自动化储存系统、自动化样品製备系统
产品 试剂、耗材、设备、软体
服务 安装和整合服务、维护和支援服务、咨询服务
科技 次世代定序、聚合酵素链锁反应、微阵列
成分 硬体和软体
应用 临床诊断、药物发现、刑事鑑定、研发
最终用户 製药和生物技术公司、医院和诊断检查室、学术研究机构
过程 样品製备、样品製备、定序与数据分析
装置 自动化工作站、自动化移液系统、自动化核酸萃取系统
解决方案 整合解决方案、独立解决方案

液体处理系统因其在样本处理方面的精确性和速度而备受关注，成为基因组学实验室不可或缺的一部分。同时，包括数据分析和管理工具在内的软体解决方案领域也已成为一个重要的成长点。这源自于基因组数据的日益复杂化以及对高阶分析的需求。自动化技术的整合正在为创新应用铺平道路，并推动基因组学领域的进一步发展。

基因组学实验室自动化市场呈现动态的市场格局，市场占有率分布、定价策略和创新产品推出均呈现变化。主要企业正利用技术进步来提升产品性能，并推动产业竞争。对基因组学应用自动化效率和准确性的追求，是推动该领域发展的关键因素。价格竞争持续不断，体现了提高通量和准确性的价值提案。频繁的新产品发布，透过展示满足不断变化的研究需求的最尖端科技，维持着强大的解决方案储备。

竞争基准分析显示，市场集中度较高，由少数主要企业主导，但同时也涌现一些提供利基解决方案的小型公司。监管的影响，尤其是在北美和欧洲，对于确保合规性和安全标准以及塑造市场动态至关重要。这些法规往往会刺激创新，因为企业都在努力满足严格的要求。对个人化医疗和基因组研究日益增长的需求进一步推动了市场发展。人工智慧和机器学习的融合正在提升数据分析能力，儘管面临高昂的初始成本和对专业人才的需求等挑战，但仍蕴藏着巨大的成长机会。

主要趋势和驱动因素：

基因组学实验室自动化市场正经历强劲成长，这主要得益于技术进步和对高通量定序日益增长的需求。关键趋势包括将人工智慧 (AI) 和机器学习技术应用于资料分析和解读能力的提升。自动化技术能够简化工作流程、减少人为错误并提高基因组研究的可重复性。个人化医疗的兴起需要快速、精准的基因组分析，而定序技术成本的下降推动了基因组检测的广泛应用，进一步刺激了这项需求。此外，新冠疫情加速了自动化解决方案的普及，以满足大规模检测和监测的迫切需求。新兴市场医疗基础设施的不断完善蕴藏着许多机会。能够提供扩充性、高性价比自动化解决方案的公司将占据有利地位，把握这项成长机会。随着相关人员寻求改善患者预后并简化监测流程，对精准医疗和基因研究的日益重视预计将持续推动市场扩张。

美国关税的影响：

全球关税和地缘政治紧张局势正对基因组学实验室自动化市场产生重大影响，尤其是在东亚地区。作为基因组学技术的领导者，日本和韩国正透过加强国内创新和建构区域合作来应对关税上涨。面对出口限制，中国正加速推动基因体学自动化技术的自给自足。台湾作为重要的半导体製造中心，虽然仍易受地缘政治波动的影响，但仍持续为实验室自动化系统提供关键组件。由于技术进步和对精准医疗需求的不断增长，全球市场呈现稳健成长态势。假设供应链保持韧​​性且地缘政治稳定，预计到2035年，该市场将显着扩张。同时，中东衝突可能扰乱全球供应链并推高能源价格，进而对营运成本产生潜在影响。

目录

第一章执行摘要

第二章 市集亮点

第三章 市场动态

  • 宏观经济分析
  • 市场趋势
  • 市场驱动因素
  • 市场机会
  • 市场限制
  • 复合年均成长率：成长分析
  • 影响分析
  • 新兴市场
  • 技术蓝图
  • 战略框架

第四章 细分市场分析

  • 市场规模及预测：依类型
    • 自动化液体处理系统
    • 自动餐盘处理机
    • 机器人系统
    • 自动化储存系统
    • 自动化样品製备
  • 市场规模及预测：依产品划分
    • 试剂和耗材
    • 装置
    • 软体
  • 市场规模及预测：依服务划分
    • 安装和整合服务
    • 维护和支援服务
    • 咨询服务
  • 市场规模及预测：依技术划分
    • 次世代定序
    • 聚合酵素链锁反应
    • 微阵列
  • 市场规模及预测：依组件划分
    • 硬体
    • 软体
  • 市场规模及预测：依应用领域划分
    • 临床诊断
    • 药物发现
    • 法医检验
    • 研究与开发
  • 市场规模及预测：依最终用户划分
    • 製药和生物技术公司
    • 医院和诊断检查室
    • 学术研究机构
  • 市场规模及预测：依製程划分
    • 样品製备
    • 样品製备
    • 定序
    • 数据分析
  • 市场规模及预测：依设备划分
    • 自动化工作站
    • 自动化移液系统
    • 自动化核酸萃取系统
  • 市场规模及预测：按解决方案划分
    • 整合解决方案
    • 独立解决方案

第五章 区域分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地区
  • 亚太地区
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲
    • 台湾
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 义大利
    • 其他欧洲地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 撒哈拉以南非洲
    • 其他中东和非洲地区

第六章 市场策略

  • 需求与供给差距分析
  • 贸易和物流限制
  • 价格、成本和利润率趋势
  • 市场渗透率
  • 消费者分析
  • 法规概述

第七章 竞争讯息

  • 市场定位
  • 市场占有率
  • 竞争基准
  • 主要企业的策略

第八章 公司简介

  • Tecan Group
  • Hamilton Company
  • Qiagen
  • Perkin Elmer
  • Agilent Technologies
  • Bio-Rad Laboratories
  • Thermo Fisher Scientific
  • Beckman Coulter
  • Eppendorf
  • Illumina
  • Roche Diagnostics
  • Fluidigm
  • Becton Dickinson
  • Analytik Jena
  • Brooks Automation
  • Hudson Robotics
  • Aurora Biomed
  • High Res Biosolutions
  • Labcyte
  • Zymo Research

第九章：关于我们

简介目录
Product Code: GIS25311

Lab Automation in Genomics Market is anticipated to expand from $2.44 billion in 2024 to $10.9 billion by 2034, growing at a CAGR of approximately 16.1%. The Lab Automation in Genomics Market encompasses technologies that streamline genomic research through automated systems, enhancing precision and throughput in DNA sequencing, PCR, and sample preparation. These innovations reduce human error and operational costs while accelerating discovery timelines. Driven by advancements in robotics and AI, this market is pivotal in personalized medicine and biotechnology, meeting increasing demands for efficiency and scalability in genomic studies.

The Lab Automation in Genomics Market is experiencing robust growth, fueled by the rising need for high-throughput sequencing and precision medicine. Within this market, the automation systems segment is the top performer, driven by the integration of advanced robotics and AI-driven platforms. These systems enhance efficiency and accuracy in genomic workflows. The consumables segment, including reagents and assay kits, follows as the second highest performer. This is due to the continuous demand for reliable and high-quality materials in genomic experiments.

Market Segmentation
TypeAutomated Liquid Handlers, Automated Plate Handlers, Robotic Systems, Automated Storage Systems, Automated Sample Preparation
ProductReagents and Consumables, Instruments, Software
ServicesInstallation and Integration Services, Maintenance and Support Services, Consulting Services
TechnologyNext-Generation Sequencing, Polymerase Chain Reaction, Microarray
ComponentHardware, Software
ApplicationClinical Diagnostics, Drug Discovery, Forensic Testing, Research and Development
End UserPharmaceutical and Biotechnology Companies, Hospitals and Diagnostic Laboratories, Academic and Research Institutes
ProcessSample Preparation, Library Preparation, Sequencing, Data Analysis
DeviceAutomated Workstations, Automated Pipetting Systems, Automated Nucleic Acid Extraction Systems
SolutionsIntegrated Solutions, Standalone Solutions

Liquid handling systems are gaining significant traction, offering precision and speed in sample processing, making them indispensable in genomics labs. Meanwhile, the software solutions sub-segment, which includes data analysis and management tools, is also emerging as a critical area of growth. This is attributable to the increasing complexity of genomic data and the need for sophisticated analysis. The convergence of automation technologies is paving the way for innovative applications, driving further advancements in the genomics landscape.

The Lab Automation in Genomics Market is characterized by a dynamic landscape of market share distribution, pricing strategies, and innovative product launches. Key players are leveraging technological advancements to enhance their product offerings, driving competitiveness within the industry. The pursuit of automation efficiency and precision in genomic applications is propelling the sector forward. Pricing remains competitive, reflecting the value proposition of enhanced throughput and accuracy. New product launches are frequent, showcasing cutting-edge technologies that cater to evolving research needs, thus maintaining a robust pipeline of solutions.

Competition benchmarking reveals a concentrated market with a few dominant players, yet smaller firms are emerging with niche solutions. Regulatory influences, particularly in North America and Europe, are pivotal in shaping market dynamics, ensuring compliance and safety standards. These regulations often drive innovation, as companies strive to meet stringent requirements. The market is further bolstered by increasing demand for personalized medicine and genomic research. The integration of AI and machine learning is enhancing data analysis capabilities, offering significant growth opportunities despite challenges like high initial costs and the need for skilled personnel.

Geographical Overview:

The Lab Automation in Genomics Market is witnessing notable growth across various regions, each presenting unique opportunities. North America remains a dominant force, driven by advanced healthcare infrastructure and significant investments in genomics research. The region's focus on personalized medicine further propels the demand for lab automation. Europe follows closely, with strong emphasis on precision medicine and government support for genomics initiatives. The region's robust regulatory framework and investment in healthcare innovation enhance market growth. In the Asia Pacific, the market is expanding rapidly, supported by technological advancements and increasing healthcare expenditure. Countries like China and India are emerging as key players, investing heavily in genomics research and automation technologies. Latin America and the Middle East & Africa are burgeoning markets with untapped potential. In Latin America, growing awareness and investments in healthcare infrastructure drive market expansion, while the Middle East & Africa focus on modernizing healthcare systems and embracing genomics advancements.

Key Trends and Drivers:

The Lab Automation in Genomics Market is experiencing robust growth, driven by technological advancements and increasing demand for high-throughput sequencing. Key trends include the integration of artificial intelligence and machine learning, which enhance data analysis and interpretation capabilities. Automation technologies are streamlining workflows, reducing human error, and improving reproducibility in genomic research. The rise of personalized medicine is a significant driver, as it necessitates rapid and accurate genomic analyses. This demand is further fueled by the decreasing costs of sequencing technologies, making genomic testing more accessible. Additionally, the COVID-19 pandemic has accelerated the adoption of automated solutions to meet the urgent need for large-scale testing and research. Opportunities abound in emerging markets where healthcare infrastructure is expanding. Companies that offer scalable and cost-effective automation solutions are well-positioned to capitalize on this growth. The increasing focus on precision medicine and genetic research is expected to sustain market expansion, as stakeholders seek to enhance patient outcomes and streamline research processes.

US Tariff Impact:

Global tariffs and geopolitical tensions are exerting considerable influence on the Lab Automation in Genomics Market, particularly in East Asia. Japan and South Korea, both leaders in genomics technology, are navigating increased tariffs by bolstering domestic innovation and forging regional alliances. China, facing export controls, is accelerating its push towards self-sufficiency in genomics automation technologies. Taiwan, a pivotal player in semiconductor manufacturing, remains vulnerable to geopolitical volatility, yet continues to supply critical components for lab automation systems. The global market is witnessing robust growth driven by technological advancements and rising demand for precision medicine. By 2035, the market is poised for significant expansion, contingent on resilient supply chains and geopolitical stability. Meanwhile, Middle East conflicts could disrupt global supply chains and elevate energy prices, impacting operational costs.

Key Players:

Tecan Group, Hamilton Company, Qiagen, Perkin Elmer, Agilent Technologies, Bio- Rad Laboratories, Thermo Fisher Scientific, Beckman Coulter, Eppendorf, Illumina, Roche Diagnostics, Fluidigm, Becton Dickinson, Analytik Jena, Brooks Automation, Hudson Robotics, Aurora Biomed, High Res Biosolutions, Labcyte, Zymo Research

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Component
  • 2.6 Key Market Highlights by Application
  • 2.7 Key Market Highlights by End User
  • 2.8 Key Market Highlights by Process
  • 2.9 Key Market Highlights by Device
  • 2.10 Key Market Highlights by Solutions

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Automated Liquid Handlers
    • 4.1.2 Automated Plate Handlers
    • 4.1.3 Robotic Systems
    • 4.1.4 Automated Storage Systems
    • 4.1.5 Automated Sample Preparation
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Reagents and Consumables
    • 4.2.2 Instruments
    • 4.2.3 Software
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Installation and Integration Services
    • 4.3.2 Maintenance and Support Services
    • 4.3.3 Consulting Services
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Next-Generation Sequencing
    • 4.4.2 Polymerase Chain Reaction
    • 4.4.3 Microarray
  • 4.5 Market Size & Forecast by Component (2020-2035)
    • 4.5.1 Hardware
    • 4.5.2 Software
  • 4.6 Market Size & Forecast by Application (2020-2035)
    • 4.6.1 Clinical Diagnostics
    • 4.6.2 Drug Discovery
    • 4.6.3 Forensic Testing
    • 4.6.4 Research and Development
  • 4.7 Market Size & Forecast by End User (2020-2035)
    • 4.7.1 Pharmaceutical and Biotechnology Companies
    • 4.7.2 Hospitals and Diagnostic Laboratories
    • 4.7.3 Academic and Research Institutes
  • 4.8 Market Size & Forecast by Process (2020-2035)
    • 4.8.1 Sample Preparation
    • 4.8.2 Library Preparation
    • 4.8.3 Sequencing
    • 4.8.4 Data Analysis
  • 4.9 Market Size & Forecast by Device (2020-2035)
    • 4.9.1 Automated Workstations
    • 4.9.2 Automated Pipetting Systems
    • 4.9.3 Automated Nucleic Acid Extraction Systems
  • 4.10 Market Size & Forecast by Solutions (2020-2035)
    • 4.10.1 Integrated Solutions
    • 4.10.2 Standalone Solutions

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Component
      • 5.2.1.6 Application
      • 5.2.1.7 End User
      • 5.2.1.8 Process
      • 5.2.1.9 Device
      • 5.2.1.10 Solutions
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Component
      • 5.2.2.6 Application
      • 5.2.2.7 End User
      • 5.2.2.8 Process
      • 5.2.2.9 Device
      • 5.2.2.10 Solutions
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Component
      • 5.2.3.6 Application
      • 5.2.3.7 End User
      • 5.2.3.8 Process
      • 5.2.3.9 Device
      • 5.2.3.10 Solutions
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Component
      • 5.3.1.6 Application
      • 5.3.1.7 End User
      • 5.3.1.8 Process
      • 5.3.1.9 Device
      • 5.3.1.10 Solutions
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Component
      • 5.3.2.6 Application
      • 5.3.2.7 End User
      • 5.3.2.8 Process
      • 5.3.2.9 Device
      • 5.3.2.10 Solutions
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Component
      • 5.3.3.6 Application
      • 5.3.3.7 End User
      • 5.3.3.8 Process
      • 5.3.3.9 Device
      • 5.3.3.10 Solutions
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Component
      • 5.4.1.6 Application
      • 5.4.1.7 End User
      • 5.4.1.8 Process
      • 5.4.1.9 Device
      • 5.4.1.10 Solutions
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Component
      • 5.4.2.6 Application
      • 5.4.2.7 End User
      • 5.4.2.8 Process
      • 5.4.2.9 Device
      • 5.4.2.10 Solutions
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Component
      • 5.4.3.6 Application
      • 5.4.3.7 End User
      • 5.4.3.8 Process
      • 5.4.3.9 Device
      • 5.4.3.10 Solutions
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Component
      • 5.4.4.6 Application
      • 5.4.4.7 End User
      • 5.4.4.8 Process
      • 5.4.4.9 Device
      • 5.4.4.10 Solutions
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Component
      • 5.4.5.6 Application
      • 5.4.5.7 End User
      • 5.4.5.8 Process
      • 5.4.5.9 Device
      • 5.4.5.10 Solutions
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Component
      • 5.4.6.6 Application
      • 5.4.6.7 End User
      • 5.4.6.8 Process
      • 5.4.6.9 Device
      • 5.4.6.10 Solutions
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Component
      • 5.4.7.6 Application
      • 5.4.7.7 End User
      • 5.4.7.8 Process
      • 5.4.7.9 Device
      • 5.4.7.10 Solutions
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Component
      • 5.5.1.6 Application
      • 5.5.1.7 End User
      • 5.5.1.8 Process
      • 5.5.1.9 Device
      • 5.5.1.10 Solutions
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Component
      • 5.5.2.6 Application
      • 5.5.2.7 End User
      • 5.5.2.8 Process
      • 5.5.2.9 Device
      • 5.5.2.10 Solutions
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Component
      • 5.5.3.6 Application
      • 5.5.3.7 End User
      • 5.5.3.8 Process
      • 5.5.3.9 Device
      • 5.5.3.10 Solutions
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Component
      • 5.5.4.6 Application
      • 5.5.4.7 End User
      • 5.5.4.8 Process
      • 5.5.4.9 Device
      • 5.5.4.10 Solutions
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Component
      • 5.5.5.6 Application
      • 5.5.5.7 End User
      • 5.5.5.8 Process
      • 5.5.5.9 Device
      • 5.5.5.10 Solutions
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Component
      • 5.5.6.6 Application
      • 5.5.6.7 End User
      • 5.5.6.8 Process
      • 5.5.6.9 Device
      • 5.5.6.10 Solutions
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Component
      • 5.6.1.6 Application
      • 5.6.1.7 End User
      • 5.6.1.8 Process
      • 5.6.1.9 Device
      • 5.6.1.10 Solutions
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Component
      • 5.6.2.6 Application
      • 5.6.2.7 End User
      • 5.6.2.8 Process
      • 5.6.2.9 Device
      • 5.6.2.10 Solutions
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Component
      • 5.6.3.6 Application
      • 5.6.3.7 End User
      • 5.6.3.8 Process
      • 5.6.3.9 Device
      • 5.6.3.10 Solutions
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Component
      • 5.6.4.6 Application
      • 5.6.4.7 End User
      • 5.6.4.8 Process
      • 5.6.4.9 Device
      • 5.6.4.10 Solutions
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Component
      • 5.6.5.6 Application
      • 5.6.5.7 End User
      • 5.6.5.8 Process
      • 5.6.5.9 Device
      • 5.6.5.10 Solutions

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Tecan Group
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Hamilton Company
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Qiagen
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Perkin Elmer
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Agilent Technologies
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Bio- Rad Laboratories
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Thermo Fisher Scientific
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Beckman Coulter
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Eppendorf
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Illumina
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Roche Diagnostics
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Fluidigm
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Becton Dickinson
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Analytik Jena
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Brooks Automation
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Hudson Robotics
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Aurora Biomed
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 High Res Biosolutions
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Labcyte
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Zymo Research
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us